506
Views
17
CrossRef citations to date
0
Altmetric
Original Article

Pirfenidone inhibits the proliferation of fibroblasts from patients with active Crohn’s disease

, , , , &
Pages 1321-1325 | Received 28 Apr 2016, Accepted 28 Apr 2016, Published online: 16 May 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Joseph Sleiman, Sara El Ouali, Taha Qazi, Benjamin Cohen, Scott R. Steele, Mark E. Baker & Florian Rieder. (2021) Prevention and Treatment of Stricturing Crohn’s Disease – Perspectives and Challenges. Expert Review of Gastroenterology & Hepatology 15:4, pages 401-411.
Read now

Articles from other publishers (16)

Ioannis Drygiannakis, George Kolios, Eirini Filidou, Giorgos Bamias & Vassilis Valatas. (2024) Intestinal Stromal Cells in the Turmoil of Inflammation and Defective Connective Tissue Remodeling in Inflammatory Bowel Disease. Inflammatory Bowel Diseases.
Crossref
Helena Tavares de Sousa & Fernando Magro. (2023) How to Evaluate Fibrosis in IBD?. Diagnostics 13:13, pages 2188.
Crossref
Jiali Wang, Fushun Kou, Xiao Han, Lei Shi, Rui Shi, Zhibin Wang, Tangyou Mao & Junxiang Li. (2022) Inflammatory bowel disease and risk of idiopathic pulmonary fibrosis: A protocol for systematic review and meta-analysis. PLOS ONE 17:6, pages e0270297.
Crossref
Si-Nan Lin, Ren Mao, Chenchen Qian, Dominik Bettenworth, Jie Wang, Jiannan Li, David H. Bruining, Vipul Jairath, Brian G. Feagan, Min-Hu Chen & Florian Rieder. (2022) Development of antifibrotic therapy for stricturing Crohn’s disease: lessons from randomized trials in other fibrotic diseases. Physiological Reviews 102:2, pages 605-652.
Crossref
Silvia D’Alessio, Federica Ungaro, Daniele Noviello, Sara Lovisa, Laurent Peyrin-Biroulet & Silvio Danese. (2021) Revisiting fibrosis in inflammatory bowel disease: the gut thickens. Nature Reviews Gastroenterology & Hepatology 19:3, pages 169-184.
Crossref
Anna‐Lena Unterweger, Alena Rüscher, Marietta Seuß, Paula Winkelmann, Florian Beigel, Leandra Koletzko, Simone Breiteneicher, Matthias Siebeck, Roswitha Gropp & Attila Aszodi. (2021) NOD/scid IL‐2Rγ null mice reconstituted with peripheral blood mononuclear cells from patients with Crohn's disease reflect the human pathological phenotype . Immunity, Inflammation and Disease 9:4, pages 1631-1647.
Crossref
Anjana Bali & Monika Rani. 2021. Crohn’s Disease Recent Advances. Crohn’s Disease Recent Advances.
Christopher J Schmoyer, Jakob Saidman, Jaime L Bohl, Claire L Bierly, John F Kuemmerle & Stephen J Bickston. (2021) The Pathogenesis and Clinical Management of Stricturing Crohn Disease. Inflammatory Bowel Diseases 27:11, pages 1839-1852.
Crossref
Sarah Rank Rønnow, Rand Qais Dabbagh, Federica Genovese, Carmel B. Nanthakumar, Vikki J. Barrett, Robert B. Good, Sarah Brockbank, Simon Cruwys, Henrik Jessen, Grith Lykke Sorensen, Morten Asser Karsdal, Diana Julie Leeming & Jannie Marie Bülow Sand. (2020) Prolonged Scar-in-a-Jar: an in vitro screening tool for anti-fibrotic therapies using biomarkers of extracellular matrix synthesis. Respiratory Research 21:1.
Crossref
Jun Hwan Yoo, Stefan Holubar & Florian Rieder. (2020) Fibrostenotic strictures in Crohn’s disease. Intestinal Research 18:4, pages 379-401.
Crossref
Giovanni Latella & Angelo Viscido. (2020) Could Pirfenidone Also be Effective in Treating Intestinal Fibrosis?. Cells 9:8, pages 1762.
Crossref
Yingying Cui, Mengfan Zhang, Changsen Leng, Tjasso Blokzijl, Bernadien H. Jansen, Gerard Dijkstra & Klaas Nico Faber. (2020) Pirfenidone Inhibits Cell Proliferation and Collagen I Production of Primary Human Intestinal Fibroblasts. Cells 9:3, pages 775.
Crossref
Tuong N. Vu, Xuesong Chen, Hussein D. Foda, Gerald C. Smaldone & Nadia A. Hasaneen. (2019) Interferon-γ enhances the antifibrotic effects of pirfenidone by attenuating IPF lung fibroblast activation and differentiation. Respiratory Research 20:1.
Crossref
Julie Stougaard, Søren Lomholt, Pernille Ommen, Jens Kelsen & Tue W. Kragstrup. (2018) The antifibrotic drug pirfenidone inhibits spondyloarthritis fibroblast-like synoviocytes and osteoblasts in vitro. BMC Rheumatology 2:1.
Crossref
Yan-Wu Sun, Yi-Yi Zhang, Xin-Jie Ke, Xue-jing Wu, Zhi-Fen Chen & Pan Chi. (2018) Pirfenidone prevents radiation-induced intestinal fibrosis in rats by inhibiting fibroblast proliferation and differentiation and suppressing the TGF-β1/Smad/CTGF signaling pathway. European Journal of Pharmacology 822, pages 199-206.
Crossref
Guanwei Li, Jianan Ren, Qiongyuan Hu, Youming Deng, Guopu Chen, Kun Guo, Ranran Li, Yuan Li, Lei Wu, Gefei Wang, Guosheng Gu & Jieshou Li. (2016) Oral pirfenidone protects against fibrosis by inhibiting fibroblast proliferation and TGF-β signaling in a murine colitis model. Biochemical Pharmacology 117, pages 57-67.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.